- $313.84m
- $318.99m
- $624.29m
- 48
- 93
- 38
- 62
Annual income statement for DocGo, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 94.1 | 319 | 441 | 624 |
Cost of Revenue | ||||
Gross Profit | 31.3 | 110 | 155 | 195 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Total Operating Expenses | 109 | 303 | 420 | 609 |
Operating Profit | -14.8 | 15.5 | 20.5 | 15.1 |
Total Net Non Operating Interest Income / Expense | ||||
Gain / Loss on Sale of Assets | ||||
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -14.6 | 19.8 | 22.8 | 16.3 |
Provision for Income Taxes | ||||
Net Income After Taxes | -14.8 | 19.2 | 30.7 | 10 |
Minority Interest | ||||
Net Income Before Extraordinary Items | ||||
Net Income | -14.4 | 23.7 | 34.6 | 6.86 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -14.4 | 23.7 | 34.6 | 6.86 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.246 | 0.249 | 0.354 | 0.071 |